Search for: "State v. Tri-State Pharmaceutical"
Results 1 - 20
of 454
Sort by Relevance
|
Sort by Date
30 May 2024, 7:34 pm
/Novartis Pharmaceuticals v. [read post]
17 May 2024, 1:07 pm
Police arrive, vehicle tries to leave, police conduct a Terry stop, and they discover the gun. [read post]
9 May 2024, 11:30 am
Wade, Griswold v. [read post]
28 Apr 2024, 11:06 am
The press release further stated that in the course of the investigation, the board had learned that the Chair of the company’s board of directors, David Nicholson, had “prior knowledge of the existence of the earlier of Dr. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
2 Apr 2024, 9:50 am
[If doctors cannot sue the FDA for failing to restrict pharmaceuticals or other products, can anyone else? [read post]
19 Feb 2024, 12:55 pm
Tri-Ergon Corp., 294 U.S. 477 (1935). [read post]
12 Feb 2024, 6:07 am
The Health Plan Excess Fee Case Filed Against Johnson and Johnson In Lewandowski v. [read post]
1 Feb 2024, 4:00 am
Rees, Glossip v. [read post]
25 Jan 2024, 5:31 am
Another is that you may have tried all approved treatments without seeing any benefits. [read post]
2 Jan 2024, 12:56 pm
Thus, by my tally there were 25 securities class action lawsuits filed against companies in the 283 SIC Code Industry Group (Drugs), including 17 in the 2834 SIC Code category (Pharmaceutical Preparations). [read post]
16 Sep 2023, 8:16 am
August 25, 2023 decision by the United States Court of Appeals for the District of Columbia Circuit in FTC v. [read post]
24 Aug 2023, 9:41 am
In parallel, Novartis tried to obtain preliminary injunctions (PIs) in several jurisdictions. [read post]
3 Aug 2023, 10:48 am
See Phillips v. [read post]
26 Jul 2023, 1:53 am
In Sun Pharma v. [read post]
6 Jul 2023, 2:55 am
Although the Court of Appeal was clear, in Neurim v Generics [2020] EWCA Civ 793, that deciding to uphold the lower court’s decision not to grant a pharmaceutical patent PI was based on the specific facts of that case, the Patents Court has subsequently refused two further pharmaceutical PIs (Neurim v Teva [2022] EWHC 954 (Pat) and [2022] EWHC 1641(Pat), and Novartis v Teva [2022] EWHC 959 (Ch)). [read post]
27 Jun 2023, 5:56 pm
He litigates pharmaceutical, environmental, mass tort and personal injury cases throughout the country. [read post]
29 May 2023, 11:43 am
” In this regard, the final version of the UPCA tries to address the criticisms of the Court of Justice, inter alia by recalling the primacy of EU law (Art. 20) by imposing on the UPC an obligation to cooperate with the CJEU through preliminary rulings for matters of EU law (Art. 21), and by rendering the Member States liable for the decisions of the UPC that would constitute a breach of EU law (Art. 22 and 23). [read post]
17 May 2023, 8:53 am
Teva Pharmaceuticals USA, Inc., the United States District Court for the District of New Jersey recently ordered that two separate, but related, Hatch-Waxman cases must be tried together. [read post]
17 May 2023, 8:53 am
Teva Pharmaceuticals USA, Inc., the United States District Court for the District of New Jersey recently ordered that two separate, but related, Hatch-Waxman cases must be tried together. [read post]
